1 day ago
5
cabuscaa/iStock via Getty Images
- GoodRx (NASDAQ:GDRX) has begun a subscription service for male customers to gain access to hair loss treatments such as the oral versions of finasteride (Propecia) and minoxidil (Rogaine).
- Potential customers have a remote consultation with a healthcare professional who will
English (US) ·